532296:BOM
Glenmark Pharmaceuticals Ltd
₹ २,२२४.००
arrow_downward
-१.१७%(-२६.३०) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
₹ २,२४९.८०
High
₹ २,२६४.००
Low
₹ २,२२४.००
Mkt. cap
६.२८ खरब
Avg. vol.
१७.९७ हजार
Volume
१२.९४ हजार
Dividend
०.२२%
Quarterly dividend
₹ १.२५
Ex-dividend date
२०२५ अक्टोबर ३
P/E ratio
३४.९२
52-wk high
₹ २,५३६.८५
52-wk low
₹ १,७९४.००
EPS
₹ ६३.६८
Shares outstanding
०.००
No. of employees
१७ हजार
Open
₹ २,२४९.८०
High
₹ २,२६४.००
Low
₹ २,२२४.००
Mkt. cap
६.२८ खरब
Avg. vol.
१७.९७ हजार
Volume
१२.९४ हजार
Dividend
०.२२%
Quarterly dividend
₹ १.२५
Ex-dividend date
२०२५ अक्टोबर ३
P/E ratio
३४.९२
52-wk high
₹ २,५३६.८५
52-wk low
₹ १,७९४.००
EPS
₹ ६३.६८
Shares outstanding
०.००
No. of employees
१७ हजार
News stories
From web sources and news partners
MarketBeat
·
२६ मिनेट पहिले
Black Rock Coffee Bar (NASDAQ:BRCB) Rating Lowered to "Strong Sell" at Zacks Research
Simply Wall Street
·
२८ मिनेट पहिले
Surprised By Recursion Pharmaceuticals’ Slide? What Investors Overlooked
ad-hoc-news.de
·
१२ मिनेट पहिले
Zacks upgrades Kingsoft Cloud stock to Strong Buy with USD 16.67 consensus target
Yahoo Finance
·
५ घण्टा पहिले
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd